These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34511726)

  • 21. Recent Advances of Point-of-Care Devices Integrated with Molecularly Imprinted Polymers-Based Biosensors: From Biomolecule Sensing Design to Intraoral Fluid Testing.
    Park R; Jeon S; Jeong J; Park SY; Han DW; Hong SW
    Biosensors (Basel); 2022 Feb; 12(3):. PubMed ID: 35323406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example.
    Kang T; Lu J; Yu T; Long Y; Liu G
    Biosens Bioelectron; 2022 Jun; 206():114109. PubMed ID: 35245867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review.
    He Z; Liu C; Li Z; Chu Z; Chen X; Chen X; Guo Y
    Front Bioeng Biotechnol; 2022; 10():1020444. PubMed ID: 36312553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study.
    Hocking L; George J; Broberg EK; Struelens MJ; Leitmeyer KC; Deshpande A; Parkinson S; Francombe J; Morley KI; de Carvalho Gomes H
    Front Public Health; 2021; 9():722943. PubMed ID: 34746078
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent Advances and Applications in Paper-Based Devices for Point-of-Care Testing.
    Hou Y; Lv CC; Guo YL; Ma XH; Liu W; Jin Y; Li BX; Yang M; Yao SY
    J Anal Test; 2022; 6(3):247-273. PubMed ID: 35039787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices.
    Li P; Lee GH; Kim SY; Kwon SY; Kim HR; Park S
    ACS Nano; 2021 Feb; 15(2):1960-2004. PubMed ID: 33534541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.
    Kumar A; Parihar A; Panda U; Parihar DS
    ACS Appl Bio Mater; 2022 May; 5(5):2046-2068. PubMed ID: 35473316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of nanodiagnostics in point-of-care tests for infectious diseases.
    Wang Y; Yu L; Kong X; Sun L
    Int J Nanomedicine; 2017; 12():4789-4803. PubMed ID: 28740385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point-of-care testing based on smartphone: The current state-of-the-art (2017-2018).
    Liu J; Geng Z; Fan Z; Liu J; Chen H
    Biosens Bioelectron; 2019 May; 132():17-37. PubMed ID: 30851493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in immunodiagnostics based on biosensor technologies-from central laboratory to the point of care.
    Poschenrieder A; Thaler M; Junker R; Luppa PB
    Anal Bioanal Chem; 2019 Nov; 411(29):7607-7621. PubMed ID: 31152226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges.
    Yang SM; Lv S; Zhang W; Cui Y
    Sensors (Basel); 2022 Feb; 22(4):. PubMed ID: 35214519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in point-of-care diagnostics for oral cancer.
    Kaur J; Srivastava R; Borse V
    Biosens Bioelectron; 2021 Apr; 178():112995. PubMed ID: 33515983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplex Molecular Point-of-Care Test for Syndromic Infectious Diseases.
    Kim H; Huh HJ; Park E; Chung DR; Kang M
    Biochip J; 2021; 15(1):14-22. PubMed ID: 33613852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomaterials-modified cellulose paper as a platform for biosensing applications.
    Ge S; Zhang L; Zhang Y; Lan F; Yan M; Yu J
    Nanoscale; 2017 Mar; 9(13):4366-4382. PubMed ID: 28155933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luminescent Covalent Organic Frameworks for Biosensing and Bioimaging Applications.
    Ma J; Shu T; Sun Y; Zhou X; Ren C; Su L; Zhang X
    Small; 2022 Jan; 18(3):e2103516. PubMed ID: 34605177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public Health Education Should Include Point-of-Care Testing: Lessons Learned from the Covid-19 Pandemic.
    Kost GJ
    EJIFCC; 2021 Oct; 32(3):311-327. PubMed ID: 34819821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point of care testing: The impact of nanotechnology.
    Syedmoradi L; Daneshpour M; Alvandipour M; Gomez FA; Hajghassem H; Omidfar K
    Biosens Bioelectron; 2017 Jan; 87():373-387. PubMed ID: 27589400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Point-of-Care Biosensors for COVID-19.
    Choi JR
    Front Chem; 2020; 8():517. PubMed ID: 32574316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in point-of-care technologies for molecular diagnostics.
    Zarei M
    Biosens Bioelectron; 2017 Dec; 98():494-506. PubMed ID: 28728010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and point-of-care diagnostics for Ebola and new threats: National POCT policy and guidelines will stop epidemics.
    Kost GJ
    Expert Rev Mol Diagn; 2018 Jul; 18(7):657-673. PubMed ID: 29933717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.